UPM-Kymmene Oyj Website

UPM-Kymmene Oyj

HLSE-UPM

Basic

  • Market Cap

    €15.88B

  • EV

    €19.19B

  • Shares Out

    533.32M

  • Revenue

    €10.3B

  • Employees

    16,776

Margins

  • Gross

    12.74%

  • EBITDA

    13.55%

  • Operating

    9.48%

  • Pre-Tax

    4.76%

  • Net

    4.19%

  • FCF

    8%

Returns (5Yr Avg)

  • ROA

    5.81%

  • ROTA

    9.55%

  • ROE

    9.18%

  • ROCE

    8.85%

  • ROIC

    7.7%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    €36.33

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    €558M

  • Net Debt

    €2,937M

  • Debt/Equity

    0.31

  • EBIT/Interest

    8.72

Growth (CAGR)

  • Rev 3Yr

    5.25%

  • Rev 5Yr

    -0.72%

  • Rev 10Yr

    0.32%

  • Dil EPS 3Yr

    -16.07%

  • Dil EPS 5Yr

    -21.69%

  • Dil EPS 10Yr

    -1.38%

  • Rev Fwd 2Yr

    4.77%

  • EBITDA Fwd 2Yr

    26.34%

  • EPS Fwd 2Yr

    39.89%

  • EPS LT Growth Est

    15.64%

Dividends

  • Yield

    —

  • Payout

    185.18%

  • DPS

    €1.5

  • DPS Growth 3Yr

    4.89%

  • DPS Growth 5Yr

    2.9%

  • DPS Growth 10Yr

    9.6%

  • DPS Growth Fwd 2Yr

    4.39%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

10,238

8,580

9,814

11,720

10,460

10,301

Total Revenues % Chg.

-2.3%

-16.2%

14.4%

19.4%

-10.8%

-14.1%

Cost of Goods Sold, Total

7,301

7,356

8,079

9,441

9,293

8,989

Gross Profit

2,937

1,224

1,735

2,279

1,167

1,312

Selling General & Admin Expenses, Total

1,216

15

25

29

23

23

Stock-Based Compensation

14

—

—

—

—

—

Depreciation & Amortization

477

471

464

442

543

512

Other Operating Expenses

-90

-121

-112

-241

-255

-200

Other Operating Expenses, Total

1,617

365

377

230

311

335

Operating Income

1,320

859

1,358

2,049

856

977

Interest Expense, Total

-45

-47

-47

-63

-87

-112

Interest And Investment Income

18

26

32

35

37

37

Net Interest Expenses

-27

-21

-15

-28

-50

-75

Income (Loss) On Equity Invest.

3

3

2

4

-1

—

Currency Exchange Gains (Loss)

3

-28

-8

-22

-109

-39

Other Non Operating Income (Expenses)

—

-9

-6

4

-27

-19

-18

EBT, Excl. Unusual Items

1,290

807

1,341

1,976

677

845

Restructuring Charges

—

—

-13

-70

-49

—

—

-82

Gain (Loss) On Sale Of Investments

—

—

—

12

133

—

—

—

Gain (Loss) On Sale Of Assets

4

13

14

37

8

8

Asset Writedown

26

-25

109

-68

-220

-281

EBT, Incl. Unusual Items

1,307

737

1,548

1,945

465

490

Income Tax Expense

234

169

240

388

71

44

Earnings From Continuing Operations

1,073

568

1,308

1,557

394

446

Minority Interest

—

—

-12

-8

-22

-31

-6

-14

Net Income

1,061

560

1,286

1,526

388

432

Net Income to Common Incl Extra Items

1,061

560

1,286

1,526

388

432

Net Income to Common Excl. Extra Items

1,061

560

1,286

1,526

388

432

Total Shares Outstanding

533.3

533.3

533.3

533.3

533.3

533.3

Weighted Avg. Shares Outstanding

533.3

533.3

533.3

533.3

533.3

533.3

Weighted Avg. Shares Outstanding Dil

533.3

533.3

533.3

533.3

533.3

533.3

EPS

2

1.1

2.4

2.9

0.7

0.8

EPS Diluted

2

1.1

2.4

2.9

0.7

0.8

EBITDA

1,717

1,246

1,729

2,424

1,304

1,396

Effective Tax Rate

17.9%

22.9%

15.5%

19.9%

15.3%

9%